nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—Fatty Acid Beta Oxidation—CPT1B—liver cancer	0.0737	0.0737	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—SCD—liver cancer	0.0479	0.0479	CbGpPWpGaD
Tyloxapol—LPL—Vitamin A and Carotenoid Metabolism—CRABP1—liver cancer	0.045	0.045	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—AHR—liver cancer	0.0427	0.0427	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—NFE2L2—liver cancer	0.0416	0.0416	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—HPGDS—liver cancer	0.0373	0.0373	CbGpPWpGaD
Tyloxapol—LPL—Vitamin A and Carotenoid Metabolism—CYP2E1—liver cancer	0.0321	0.0321	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—SCD—liver cancer	0.0288	0.0288	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—ADAM17—liver cancer	0.0229	0.0229	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—CYP1A1—liver cancer	0.0218	0.0218	CbGpPWpGaD
Tyloxapol—LPL—Lipoprotein metabolism—ALB—liver cancer	0.0209	0.0209	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—AHR—liver cancer	0.0186	0.0186	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—CYCS—liver cancer	0.0185	0.0185	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—ESR1—liver cancer	0.0181	0.0181	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—ALB—liver cancer	0.0139	0.0139	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—RAF1—liver cancer	0.0134	0.0134	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—PPARA—liver cancer	0.0132	0.0132	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	0.0123	0.0123	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.012	0.012	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—PPARG—liver cancer	0.0119	0.0119	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—EFNB2—liver cancer	0.0117	0.0117	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	0.0114	0.0114	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—PPARG—liver cancer	0.0109	0.0109	CbGpPWpGaD
Tyloxapol—LPL—Disease—APCS—liver cancer	0.0105	0.0105	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	0.0102	0.0102	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—MTOR—liver cancer	0.00948	0.00948	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—MYC—liver cancer	0.00941	0.00941	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—TNF—liver cancer	0.00877	0.00877	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—PPARA—liver cancer	0.0087	0.0087	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.0087	0.0087	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—CASP3—liver cancer	0.00782	0.00782	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00774	0.00774	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00746	0.00746	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.00739	0.00739	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—PPARG—liver cancer	0.00719	0.00719	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TRIO—liver cancer	0.00698	0.00698	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TCF4—liver cancer	0.00656	0.00656	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—SERPINE1—liver cancer	0.00648	0.00648	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—TGFB1—liver cancer	0.00622	0.00622	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—TNF—liver cancer	0.00581	0.00581	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—PIK3CA—liver cancer	0.00578	0.00578	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.0057	0.0057	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—HNF4A—liver cancer	0.00569	0.00569	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TNF—liver cancer	0.00569	0.00569	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—UGDH—liver cancer	0.00569	0.00569	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CHN2—liver cancer	0.00559	0.00559	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—EPT1—liver cancer	0.00535	0.00535	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IFT88—liver cancer	0.00511	0.00511	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—TAT—liver cancer	0.00507	0.00507	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—CTNNB1—liver cancer	0.00506	0.00506	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TP53—liver cancer	0.00501	0.00501	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.00499	0.00499	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—CDKN1A—liver cancer	0.00494	0.00494	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—AKT1—liver cancer	0.00472	0.00472	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—STAT3—liver cancer	0.00441	0.00441	CbGpPWpGaD
Tyloxapol—LPL—Disease—LTF—liver cancer	0.00411	0.00411	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—TGFB1—liver cancer	0.00409	0.00409	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—TNF—liver cancer	0.00382	0.00382	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.00373	0.00373	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ABL1—liver cancer	0.00367	0.00367	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CPT1B—liver cancer	0.00345	0.00345	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GLUL—liver cancer	0.00345	0.00345	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NR1H4—liver cancer	0.00332	0.00332	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTA3—liver cancer	0.00327	0.00327	CbGpPWpGaD
Tyloxapol—LPL—Disease—ALDOB—liver cancer	0.00318	0.00318	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SHC3—liver cancer	0.00313	0.00313	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—IL6—liver cancer	0.00308	0.00308	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PPARA—liver cancer	0.00299	0.00299	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTA4—liver cancer	0.00299	0.00299	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.00292	0.00292	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTA2—liver cancer	0.00291	0.00291	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTA1—liver cancer	0.00281	0.00281	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—KDR—liver cancer	0.00278	0.00278	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NAT2—liver cancer	0.00278	0.00278	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MAPK14—liver cancer	0.00276	0.00276	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MET—liver cancer	0.00272	0.00272	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.00267	0.00267	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALDOB—liver cancer	0.00266	0.00266	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CRABP1—liver cancer	0.00254	0.00254	CbGpPWpGaD
Tyloxapol—LPL—Disease—ADAM17—liver cancer	0.00251	0.00251	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PPARG—liver cancer	0.00247	0.00247	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FST—liver cancer	0.00243	0.00243	CbGpPWpGaD
Tyloxapol—LPL—Disease—PSMD10—liver cancer	0.00236	0.00236	CbGpPWpGaD
Tyloxapol—LPL—Disease—PSMA4—liver cancer	0.00236	0.00236	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TRIO—liver cancer	0.00232	0.00232	CbGpPWpGaD
Tyloxapol—LPL—Disease—GOT2—liver cancer	0.0023	0.0023	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.00229	0.00229	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP2—liver cancer	0.00227	0.00227	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCR4—liver cancer	0.00223	0.00223	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HPGDS—liver cancer	0.00222	0.00222	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.00221	0.00221	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.00201	0.00201	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—RAF1—liver cancer	0.00201	0.00201	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.00198	0.00198	CbGpPWpGaD
Tyloxapol—LPL—Disease—GOT1—liver cancer	0.00198	0.00198	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PSMA4—liver cancer	0.00198	0.00198	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PSMD10—liver cancer	0.00198	0.00198	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GOT2—liver cancer	0.00192	0.00192	CbGpPWpGaD
Tyloxapol—LPL—Disease—PRKCE—liver cancer	0.00183	0.00183	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP2E1—liver cancer	0.00181	0.00181	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADAM17—liver cancer	0.00176	0.00176	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.00175	0.00175	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CTNNB1—liver cancer	0.00174	0.00174	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP9—liver cancer	0.00171	0.00171	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYCS—liver cancer	0.00169	0.00169	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GOT1—liver cancer	0.00166	0.00166	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GGT1—liver cancer	0.00166	0.00166	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PSMA4—liver cancer	0.00165	0.00165	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PSMD10—liver cancer	0.00165	0.00165	CbGpPWpGaD
Tyloxapol—LPL—Disease—H2AFX—liver cancer	0.0016	0.0016	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—VEGFA—liver cancer	0.00153	0.00153	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—STAT3—liver cancer	0.00152	0.00152	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTP1—liver cancer	0.00149	0.00149	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HMOX1—liver cancer	0.00147	0.00147	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTHFR—liver cancer	0.00145	0.00145	CbGpPWpGaD
Tyloxapol—LPL—Disease—TERT—liver cancer	0.00144	0.00144	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TGFB1—liver cancer	0.00141	0.00141	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTM1—liver cancer	0.00137	0.00137	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TNF—liver cancer	0.00131	0.00131	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—KRAS—liver cancer	0.0013	0.0013	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP1A1—liver cancer	0.0013	0.0013	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRKCE—liver cancer	0.00128	0.00128	CbGpPWpGaD
Tyloxapol—LPL—Disease—APC—liver cancer	0.00122	0.00122	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF2—liver cancer	0.00121	0.00121	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MTHFR—liver cancer	0.00121	0.00121	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARA—liver cancer	0.00119	0.00119	CbGpPWpGaD
Tyloxapol—LPL—Disease—BRAF—liver cancer	0.00114	0.00114	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CSF2—liver cancer	0.00113	0.00113	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—H2AFX—liver cancer	0.00112	0.00112	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—HRAS—liver cancer	0.00111	0.00111	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CD—liver cancer	0.00107	0.00107	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.00107	0.00107	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—IL6—liver cancer	0.00106	0.00106	CbGpPWpGaD
Tyloxapol—LPL—Disease—SERPINE1—liver cancer	0.00106	0.00106	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CG—liver cancer	0.00102	0.00102	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TERT—liver cancer	0.00101	0.00101	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARG—liver cancer	0.000983	0.000983	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—AKT1—liver cancer	0.000977	0.000977	CbGpPWpGaD
Tyloxapol—LPL—Disease—RAF1—liver cancer	0.000954	0.000954	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CB—liver cancer	0.000932	0.000932	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTOR—liver cancer	0.000932	0.000932	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KDR—liver cancer	0.000924	0.000924	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAPK14—liver cancer	0.000918	0.000918	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ESR1—liver cancer	0.000901	0.000901	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CD—liver cancer	0.000895	0.000895	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—F2—liver cancer	0.00089	0.00089	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALB—liver cancer	0.000884	0.000884	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN1B—liver cancer	0.000875	0.000875	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CG—liver cancer	0.000852	0.000852	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APC—liver cancer	0.000852	0.000852	CbGpPWpGaD
Tyloxapol—LPL—Disease—CTNNB1—liver cancer	0.000826	0.000826	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN1A—liver cancer	0.000807	0.000807	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—BRAF—liver cancer	0.0008	0.0008	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CB—liver cancer	0.00078	0.00078	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CD—liver cancer	0.000749	0.000749	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SERPINE1—liver cancer	0.00074	0.00074	CbGpPWpGaD
Tyloxapol—LPL—Disease—STAT3—liver cancer	0.00072	0.00072	CbGpPWpGaD
Tyloxapol—LPL—Disease—MYC—liver cancer	0.000669	0.000669	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RAF1—liver cancer	0.000668	0.000668	CbGpPWpGaD
Tyloxapol—LPL—Disease—TGFB1—liver cancer	0.000668	0.000668	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MTOR—liver cancer	0.000653	0.000653	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CB—liver cancer	0.000653	0.000653	CbGpPWpGaD
Tyloxapol—LPL—Disease—KRAS—liver cancer	0.000618	0.000618	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN1B—liver cancer	0.000612	0.000612	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CASP3—liver cancer	0.0006	0.0006	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL2—liver cancer	0.000599	0.000599	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCND1—liver cancer	0.000584	0.000584	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—JUN—liver cancer	0.000583	0.000583	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CTNNB1—liver cancer	0.000579	0.000579	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CA—liver cancer	0.000568	0.000568	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MMP9—liver cancer	0.000567	0.000567	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN1A—liver cancer	0.000565	0.000565	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAPK8—liver cancer	0.000552	0.000552	CbGpPWpGaD
Tyloxapol—LPL—Disease—HRAS—liver cancer	0.000526	0.000526	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VEGFA—liver cancer	0.000509	0.000509	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STAT3—liver cancer	0.000504	0.000504	CbGpPWpGaD
Tyloxapol—LPL—Disease—IL6—liver cancer	0.000503	0.000503	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CA—liver cancer	0.000476	0.000476	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MYC—liver cancer	0.000469	0.000469	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TGFB1—liver cancer	0.000467	0.000467	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKT1—liver cancer	0.000464	0.000464	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KRAS—liver cancer	0.000433	0.000433	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CA—liver cancer	0.000398	0.000398	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AKT1—liver cancer	0.000389	0.000389	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TP53—liver cancer	0.000385	0.000385	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HRAS—liver cancer	0.000368	0.000368	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL6—liver cancer	0.000352	0.000352	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKT1—liver cancer	0.000325	0.000325	CbGpPWpGaD
